Sakar Healthcare Limited vs Torrent Pharmaceuticals Limited
A side-by-side comparison of Sakar Healthcare Limited (SAKAR) and Torrent Pharmaceuticals Limited (TORNTPHARM) — valuation, profitability, growth, and financial health — to help you judge which is the stronger buy today.
On the numbers, Torrent Pharmaceuticals Limited leads SAKAR vs TORNTPHARM on 9 of 14 metrics. See the breakdown below — the right pick still depends on your goals (value vs growth, risk appetite).
- Valuation22
- Profitability04
- Growth20
- Size & financial health13
Each axis shows this group's split of that metric, scaled so the leader sits at the edge. Relative to each other, not an absolute score.
Valuation
EvenHow expensive each stock is relative to its earnings and book value. Lower usually means cheaper.
Profitability
TORNTPHARM takes 4/4How efficiently each company turns capital and sales into profit. Higher is better.
Growth
SAKAR takes 2/2Three-year compounded growth. Faster-growing businesses can justify a higher valuation.
Size & financial health
TORNTPHARM takes 3/4Scale and balance-sheet strength. Bigger revenue/profit and lower debt are generally safer.
- + ["Company has delivered good profit growth of 22.6% CAGR over last 5 years", "Company has delivered good sales growth of 21.5% CAGR over last 5 years"]
- − ["Stock is trading at 6.60 times its book value", "Company has a low return on equity of 7.3% over last 3 years.", "Though the company is reporting repeated profits, it is not paying out dividend"]
- + ["Company has a good return on equity (ROE) track record: 3 Years ROE 26.2%", "Company has been maintaining a healthy dividend payout of 67.6%"]
- − ["Stock is trading at 20.67 times its book value", "Company has a high debt to equity ratio of 1.79."]
This comparison is for informational purposes only and is not investment advice. Please consult a SEBI-registered advisor before investing.